USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $-0.13 | $-0.14 | $-0.16 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $0.00 | $0.00 | $0.00 |
Hoth Therapeutics's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 2 | $-0.14 | $-0.16 | $-0.13 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 2 | $-0.63 | $-0.66 | $-0.60 |
| Dec 2022 | 2 | $-0.60 | $-0.62 | $-0.58 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-0.14 | $-0.19 | $-0.19 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-0.63 | $-0.77 | $-0.77 |
| Dec 2022 | 0 / 0 | $-0.60 | $-0.59 | $-0.59 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 2 | $0.00 | $0.00 | $0.00 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 2 | $0.00 | $0.00 | $0.00 |
| Dec 2022 | 2 | $0.00 | $0.00 | $0.00 |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $-0.13 | - | - |
| Aug 11, 2021 | Jun 2021 | $-0.17 | $-0.14 | 17.65% |
| May 13, 2021 | Mar 2021 | $-0.10 | $-0.24 | -140.00% |
| Mar 16, 2021 | Dec 2020 | $-0.10 | $-0.04 | 60.00% |
| Nov 10, 2020 | Sep 2020 | $-0.14 | $-0.16 | -18.52% |
| Aug 13, 2020 | Jun 2020 | $-0.14 | $-0.20 | -48.15% |
| May 13, 2020 | Mar 2020 | $-0.17 | $-0.18 | -7.98% |
| Mar 2, 2020 | Dec 2019 | $-0.14 | $-0.41 | -199.93% |
| Nov 12, 2019 | Sep 2019 | $-0.10 | $-0.17 | -64.57% |
| Aug 14, 2019 | Jun 2019 | $-0.11 | $-0.13 | -18.18% |
| Apr 1, 2019 | Mar 2019 | - | $-0.12 | - |
| Mar 31, 2019 | Dec 2018 | - | $-0.06 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 16, 2021 | Dec 2020 | $-0.63 | $-0.58 | - |
| Mar 2, 2020 | Dec 2019 | $-0.53 | $-0.83 | - |
| Mar 31, 2019 | Dec 2018 | - | $-0.06 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $0.00 | - | - |
| Aug 11, 2021 | Jun 2021 | $0.00 | $0.00 | - |
| May 13, 2021 | Mar 2021 | $0.00 | $0.00 | - |
| Mar 16, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Nov 10, 2020 | Sep 2020 | $0.00 | $0.00 | - |
| Aug 13, 2020 | Jun 2020 | $0.00 | $0.00 | - |
| May 13, 2020 | Mar 2020 | $0.00 | $0.00 | - |
| Mar 2, 2020 | Dec 2019 | $0.00 | $0.00 | - |
| Nov 12, 2019 | Sep 2019 | $0.00 | $0.00 | - |
| Aug 14, 2019 | Jun 2019 | $0.00 | $0.00 | - |
| Apr 1, 2019 | Mar 2019 | - | $0.00 | - |
| Mar 31, 2019 | Dec 2018 | - | $0.00 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 16, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Mar 2, 2020 | Dec 2019 | $0.00 | $0.00 | - |
| Mar 31, 2019 | Dec 2018 | - | $0.00 | - |
HOTH's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.
According to 2 analysts, the average EPS estimation for Hoth Therapeutics's next quarterly earnings is $-0.13, with a low EPS estimation of $-0.15, and a high estimation of $-0.12.
Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.13, the last 2 month trend is $-0.17, and the 3 month trend is $-0.17.
Based on 2 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.
Hoth Therapeutics's previous earnings date was Aug 11, 2021 for its fiscal quarter ended Jun 30, 2021.
HOTH's earnings per share (EPS) was $-0.14, beating the consensus analysts forecast of $-0.17 by 17.65%.
The EPS was higher than the previous fiscal quarter (Mar 2021) by -41.67%, and higher than the same period a year before (Jun 2020) by -30.00%.
Revenues were $0.00.
The company reported a net income of $-3.28M.Free cash flow for the quarter was $-2.70M , compared to $-2.79M last quarter and $-2.44M a year before.
Hoth Therapeutics's previous annual earnings date was Mar 16, 2021 for its fiscal year ended Dec 31, 2020.
HOTH's earnings per share (EPS) was $-0.58, beating the consensus analysts forecast of $-0.63 by -7.94% , and higher than the previous year's EPS (Dec 2019) by -29.99%.
Revenues were $0.00.
The company reported a net income of $-7.20M.
Hoth Therapeutics reported a free cash flow of $-6.30M for its fiscal year, compared to $-5.04M a year ago.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.